# Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma

> **NCT01920932** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 77 (actual)

## Conditions studied

- Stage II Childhood Hodgkin Lymphoma
- Stage III Childhood Hodgkin Lymphoma
- Stage IV Childhood Hodgkin Lymphoma

## Interventions

- **DRUG:** brentuximab vedotin
- **DRUG:** etoposide
- **DRUG:** prednisone
- **DRUG:** doxorubicin
- **DRUG:** cyclophosphamide
- **DRUG:** Dacarbazine(R)
- **DRUG:** filgrastim
- **OTHER:** quality of life assessment
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT01920932
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-08-12
- **Primary completion:** 2020-11-16
- **Final completion:** 2028-05
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01920932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01920932, "Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01920932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*